Binance founder Changpeng Zhao (CZ) mocked gold advocate Peter Schiff by sharing a viral video compiling Schiff's 13 years of Bitcoin crash predictions, where Schiff repeatedly called Bitcoin a Ponzi scheme and predicted it would fall to zero. Despite these calls, Bitcoin has remained strong, trading near $82,500, a level Schiff himself admits he cannot explain. CZ highlighted that Schiff might be right one day, but only after changing his mind. This ongoing feud reflects the broader divide between gold supporters and Bitcoin believers, with neither side showing signs of conceding.
The ongoing debate between Binance founder CZ and gold advocate Peter Schiff about Bitcoin is the story's subject, with Pluang providing a snapshot of the broader cryptocurrency market as of Oct 19, 2026 18:21 WIB. Among 50 major cryptocurrencies on Pluang, 23 rose and 25 fell today. Notably, THETA declined by 2.04% to Rp3.369 with a typical hold time of 78 days, while AXS fell 1.83% to Rp18.020 but showed 100% buy order activity, and AAVE dropped 1.75% to Rp2.711.732 with a 60% buy order activity and a longer typical hold time of 106 days.
Nyxoah announced preliminary Q3 2026 revenue of €9.2 million, up 19% sequentially, driven by a 29% increase in U.S. sales. The company submitted a PMA supplement to the FDA to expand its Genio device indication for patients with complete concentric c...
ASML Holding N.V. announced recent transactions under its ongoing share buyback program, repurchasing a total of 233,867 shares between October 12 and October 16, 2026. The shares were bought back at weighted average prices ranging from €1,444.83 to ...
The Phase 3 ALKIVIA trial demonstrated that efgartigimod significantly improves symptoms in patients with autoimmune myositis, including immune-mediated necrotizing myopathy (IMNM) and dermatomyositis (DM). Patients showed meaningful clinical improve...
In 2025, Berkshire Hathaway, led by Greg Abel, received $479 million in dividends from its $1.3 billion investment in American Express. This highlights the value of holding strong dividend-paying stocks for steady income. Retail investors can apply s...
Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...
